Oncologic outcomes of adjuvant chemotherapy in patients with risk factors after radical surgery in FIGO stage IB-IIA cervical cancer

被引：0
|
作者：
Lee, K. B. [1 ]
Lee, J. M. [2 ]
Kim, Y. S. [1 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Incheon, South Korea
[2] Kyung Hee Univ, East West Neo Med Ctr, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
下载
收藏
页码：8 / 10
页数：5
相关论文
共 50 条
  • [21] A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY AFTER RADICAL HYSTERECTOMY IN STAGE IB-IIA CERVICAL-CANCER PATIENTS WITH PELVIC LYMPH-NODE METASTASES
    TATTERSALL, MHN
    RAMIREZ, C
    COPPLESON, M
    GYNECOLOGIC ONCOLOGY, 1992, 46 (02) : 176 - 181
  • [22] Patterns of care for FIGO stage IB-IIA cervical cancer across the United States
    Pereira, E.
    Nair, N.
    Schwartz, M. A.
    Gorski, J.
    Dottino, P.
    Kolev, V.
    Gupta, V.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 181 - 181
  • [23] Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors
    Shibuya, Yusuke
    Shimada, Muneaki
    Tsuji, Keita
    Shigeta, Shogo
    Tanase, Yasuhito
    Matsuo, Koji
    Yamaguchi, Satoshi
    Kanao, Hiroyuki
    Saito, Toshiaki
    Mikami, Mikio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (11) : 1289 - 1296
  • [24] Incidence and Risk Factors of Lower-Extremity Lymphedema After Radical Surgery With or Without Adjuvant Radiotherapy in Patients With FIGO Stage I to Stage IIA Cervical Cancer
    Kim, Jin Hwi
    Choi, Ji Hyang
    Ki, Eun Young
    Lee, Sung Jong
    Yoon, Joo Hee
    Lee, Keun Ho
    Park, Tae Chul
    Park, Jong Sup
    Bae, Seog Nyeon
    Hur, Soo Young
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (04) : 686 - 691
  • [25] Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer
    Canaz, Emel
    Ozyurek, Eser Sefik
    Erdem, Baki
    Talmac, Merve Aldikactioglu
    Ozaydin, Ipek Yildiz
    Akbayir, Ozgur
    Numanoglu, Ceyhun
    Ulker, Volkan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1722 - 1728
  • [26] Adjuvant chemotherapy versus radiation therapy after radical surgery in high-risk positive node Stage IB/IIA cervical cancer
    Mossa, B.
    Mossa, S.
    Marziani, R.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (05) : 545 - 550
  • [27] Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer
    Zhai, Wenyu
    Duan, Fangfang
    Li, Dongxia
    Yan, Qihang
    Dai, Shuqin
    Zhang, Bei
    Wang, Junye
    EJSO, 2022, 48 (04): : 752 - 760
  • [28] TREATMENT RESULTS OF DIFFERENT POSTOPERATIVE ADJUVANT THERAPY FOR STAGE IB-IIA CERVICAL CARCINOMA WITH RISK FACTORS
    Wen, H.
    Huang, O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [29] Adjuvant chemotherapy with paclitaxel and cisplatin after radical hysterectomy in patients with intermediate- and high-risk stage IB-IIA cervical cancer: A matched case-control study
    Kim, J.
    Chun, K.
    Kim, D.
    Kim, J.
    Kim, Y.
    Kim, Y.
    Nam, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S44 - S45
  • [30] Outcomes of adjuvant chemotherapy only after radical surgery for stage IIIC cervical cancer patients
    Lee, Kwang Beom
    Lee, Jong-Min
    Kim, Young Saing
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S78 - S78
12345